Stratagene (www.stratagene.com) entered into a joint development and license agreement with Rosetta Inpharmatics (www.rii.com) to create an automated solution for the isolation of nucleic acids from a variety of clinical samples. Stratagene and Rosetta will develop an instrument and a single-use consumable that will be manufactured and commercialized by Stratagene. These products will be sold to Stratagene’s current customer base and companies engaged in pharmacogenomics.
